Recon: FDA authorizes Pfizer booster for 16 and 17 year olds; China approves Brii Biosciences’ COVID antibody

Recon

ReconMichael Mezher

Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy